Press Releases
The latest news and announcements from TeselaGen.

TeselaGen Releases Alpha Version of Tesela Copilot: An AI Agent for Accelerating Life Science Innovation
TeselaGen unveiled an agentic Copilot integrated with its Platform for Biological R&D, leveraging artificial intelligence to streamline experiment planning, accelerate data analysis, and enhance bioproduct development.

TeselaGen Launches Its Next-Gen Electronic Lab Notebook and Enhanced Interface to Accelerate Biotech Research
TeselaGen introduced a cutting-edge Electronic Lab Notebook with enhanced user interface, offering real-time collaboration, secure data management, and intuitive navigation fully integrated with its platform.

TeselaGen Announces Spin-Off, Built Biotechnologies, Aims to Advance DNA Manufacturing
TeselaGen launched Built Biotechnologies as a spin-off to revolutionize DNA manufacturing, specializing in advanced DNA workflows for cell and gene therapies.
TeselaGen Receives Two New Patents for Using Artificial Intelligence to Accelerate Biotech Product Development
TeselaGen acquired two patents advancing AI-driven optimization of biological phenotypes, reinforcing its intellectual property position in revolutionizing biotech development.

TeselaGen Biotechnology Renews Partnership with Joint BioEnergy Institute to Enhance Production of Carbon Neutral Bioproducts
TeselaGen and JBEI renewed their partnership through 2027, combining innovative technology with biofuel research to drive sustainable bioproducts production.

TeselaGen and NinthBio Partner to Empower Users with Advanced DNA Variant Library Construction
TeselaGen integrated NinthBio's Homology Path Design Algorithm, enabling researchers to design oligo assembly reactions and automate setup within a single platform.

TeselaGen Helps Early-Stage BioTech Startups Scale Faster and More Efficiently with Its Starter Edition
TeselaGen introduced Starter Edition, helping early-stage biotech startups accelerate DNA assembly design and high-throughput DNA library construction.

TeselaGen Biotechnology Launches Starter Edition for Small Groups to Accelerate Product Development
TeselaGen released Starter Edition, a cloud-based software platform designed for small groups in academia and industry.

TeselaGen Biotechnology Launches Open, Cloud-based Community Edition for Designing DNA
TeselaGen announced its free Community Edition, providing cloud-based access to previously unavailable tools for DNA construct design.

TeselaGen Secures Contract from BioMADE to Accelerate US Biomanufacturing with Advanced Informatics and Artificial Intelligence
TeselaGen contracted with BioMADE to improve informatics infrastructure around fermentation-based biomanufacturing, developing technologies to standardize data exchange and enable AI-enabled collaboration.

TeselaGen Biotechnology Teams Up with iGEM to Advance Synthetic Biology in Developing Countries
Partnership with iGEM Foundation supports the Design League competition, providing students access to TeselaGen's operating system for synthetic biology projects addressing local challenges in Latin America.

TeselaGen Biotechnology Partners with Agile BioFoundry to Develop Tools for Optimizing Fermentation with Machine Learning
Collaboration aims to deploy machine learning models on community-generated data to accelerate biomanufacturing and commercialization of bioproducts.

TeselaGen Biotechnology Releases New Protein Optimization Toolkit for Automated Biotherapeutic Drug Design and Development
New functionality accelerates design and development processes, reducing R&D costs for biotherapeutics and vaccines.

Phycus Biotechnologies and TeselaGen Biotechnology Partner to Accelerate the Production of Biome-friendly Ingredients for Cosmetics
Collaboration and licensing agreement providing access to TeselaGen's AI-enabled operating system for biotechnology.

TeselaGen Partners with Berkeley Lab's Advanced Biofuels and Bioproducts Process Development Unit to Accelerate the Bioeconomy
Deployment of TeselaGen's AI-enabled operating system bridges research and large-scale fermentation-based production of renewable bioproducts.

LanzaTech and TeselaGen Biotechnology Sign New Multi-Year Deal to Advance Carbon Remediation via Biological Processes
Five-year agreement extends partnership through 2025, using synthetic biology to reduce human carbon footprint.

Ansa Biotechnologies partners with TeselaGen Biotechnology to enable commercial production of DNA products
Partnership between enzyme-based DNA production company and TeselaGen's integrated enterprise software operating system.

Machine Learning and Synthetic Biology used to Optimize a Cellular Factory for Industrially Relevant Products
Collaboration among Technical University of Denmark, Lawrence Berkeley National Laboratory, and TeselaGen demonstrates combining mechanistic and machine learning models for genotype-to-phenotype predictions.

Collaboration of four biotech companies showcases high throughput DNA assembly platform for diverse applications
Partnership among TeselaGen, Arzeda, Twist Bioscience, and Labcyte demonstrates state-of-the-art DNA assembly platform.

Arzeda leverages scalable Synthetic Biology resources to drive computational protein design platform
Partnership reduces time and cost for building genes encoding designed proteins through optimized information flow.

LanzaTech and TeselaGen Sign Deal to use Artificial Intelligence to further the Sustainable BioEconomy
LanzaTech licenses TeselaGen's cloud-based informatics solution and collaborates to extend biological design platform with AI capabilities.

Arzeda and TeselaGen Partner to Advance Biodesign Technologies for Industrial Biotechnology
Arzeda licenses TeselaGen's cloud-based informatics solution to extend biological design automation platform capabilities.

DOW AgroSciences and TeselaGen Expanding Advanced Biodesign Platform for Agriculture
Collaboration to produce a state-of-the-art biological design automation platform for accelerating agricultural discovery.

DOE Renews Funding for Joint BioEnergy Institute at Berkeley Lab
JBEI receives DOE funding renewal with support from TeselaGen for biofuels and bioproducts research.

TeselaGen Receives $500,000 Award for Gene Editing and Engineering Software
TeselaGen awarded $500,000 matching grant to develop enterprise software platform for gene editing and engineering.

Takara Bio USA, Inc. And TeselaGen Biotechnology, Inc. Release A Powerful New Primer Tool For Easy Design Of In-Fusion Cloning Experiments
Release of In-Fusion Cloning Primer Design Tool that generates primer sequences and vector maps.

Dow AgroSciences and TeselaGen Advance Biodesign Technologies for Agriculture
Collaboration announcement to produce biological design automation platform for accelerating agricultural discovery work.

TeselaGen receives NSF SBIR Award
$750,000 NSF Phase II grant to expand computer-aided DNA design platform using synthetic biology techniques.

Redbiotec and TeselaGen to Partner on Herpesvirus vaccine library
Joint venture to build rapid design and prototyping infrastructure for Herpesvirus vaccine development library.

Genomatica Licenses TeselaGen Software For DNA Design
Multi-year licensing agreement for TeselaGen's synthetic biology software to accelerate organism development from renewable feedstocks.

TeselaGen Wins A Second NSF SBIR Award
TeselaGen Biotechnology has secured a second National Science Foundation Small Business Innovation and Research grant to pursue 'Directed DNA Synthesis and Assembly'.

TeselaGen Wins NSF SBIR Award
TeselaGen Biotechnology has secured a National Science Foundation Small Business Innovation and Research grant to pursue 'A Synthetic Biology Design-Build-Test Platform.'
Try Tesela AI for free
Design libraries, generate protocols, and optimize experiments with AI agents. No credit card required.